Secarna is a new breed biopharmaceutical company based in Munich, Germany, We have developed a proprietary drug discovery platform, LNAplus™, for the next generation of antisense oligonucleotides.
Together with our partners in academia and industry, we have advanced multiple innovative antisense therapies into various stages of pre-clinical development in the areas of immuno-oncology, ophthalmology, immunology, fibrotic diseases (airways, liver, kidney), and anti-viral applications.